Promyelocytic leukaemia (PML) protein expression in human placenta and choriocarcinoma
- 14 April 2003
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 201 (1) , 83-89
Abstract
Promyelocytic leukaemia (PML) protein, the product of the pml gene, is heterogeneously expressed in various normal and neoplastic tissues, and the fusion of the pml gene with retinoic acid receptor‐α is believed to be a central mechanism in acute PML tumourigenesis. As PML is important for controlling major cellular processes, such as growth and differentiation, it is believed that it plays an important role during human gestation. The human placenta is a critical organ for the maintenance of gestation, but the expression pattern and functional significance of PML in the placenta have not been documented. The present study has therefore investigated the expression of PML in the human placenta and in choriocarcinoma, and has observed the biological effects following the overexpression of PML in choriocarcinoma cell lines (BeWo and JEG‐3). In the human placenta, PML expression was readily found in villous stromal fibroblasts, capillary endothelial cells, Hofbauer cells, and occasionally in amnion cells. Moreover, immunoblotting of placental lysates demonstrated increased PML expression with increasing gestation. Interestingly, PML expression was confined to intermediate trophoblasts and syncytiotrophoblastic giant cells at the placental site (placental site giant cells) in the trophoblastic cell population. Intermediate trophoblasts at non‐placental sites, and villous cytotrophoblasts and syncytiotrophoblasts consistently did not express PML. Further screening of PML expression in hydatidiform moles (n = 4) and choriocarcinomas (n = 7) also revealed selective PML expression in intermediate trophoblastic cells and syncytiotrophoblastic cells, but not in the cytotrophoblastic populations, which corresponds well with observations in the placental bed. Adenoviral transduction of PML resulted in a marked reduction in cell growth in both choriocarcinoma cell lines, which was associated with increased apoptosis. The findings of the present study strongly suggest that PML plays an important role in human placental development and growth, and in the pathobiology of trophoblasts and trophoblastic neoplasia. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- PML-RARα Alleviates the Transcriptional Repression Mediated by Tumor Suppressor RbJournal of Biological Chemistry, 2001
- PML interaction with p53 and its role in apoptosis and replicative senescenceOncogene, 2001
- Structure, Organization, and Dynamics of Promyelocytic Leukemia Protein Nuclear BodiesThe American Journal of Human Genetics, 1998
- PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.Journal of Experimental Medicine, 1995
- The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsCell, 1993
- Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic LeukemiaScience, 1991
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- The pattern of interstitial trophoblasticinvasion of the myometrium in early human pregnancyPlacenta, 1981
- MORPHOLOGICAL CHANGES OF THE SPIRAL ARTERIES IN THE PLACENTAE BED IN RELATION TO PRE‐ECLAMPSIA AND FETAL GROWTH RETARDATIONBJOG: An International Journal of Obstetrics & Gynaecology, 1981